1.A Case of Congenital Midline Cervical Cleft Associated with Congenital Cardiac Anomaly.
Kyung Lok KIM ; Eui Chang JUNG
Korean Journal of Dermatology 2003;41(8):1076-1078
Congenital midline cervical cleft is a rare congenital anomaly of the ventral neck. Less than 100 cases have been reported in the literature. This anomaly is part of a spectrum of midline branchiogenic syndromes resulting from abnormal migration of cells derived from the branchial arches. It presents as a small skin tag superiorly with a linear, ventrically oriented atrophic patch. We present a case of congenital midline cervical cleft associated with congenital cardiac anomaly.
Branchial Region
;
Neck
;
Skin
2.A Case of Alopecia Mucinosa Occurring in the Nasal Canal of a Child.
Kyung Lok KIM ; Jung Sub YEUM ; Eui Chang CHUNG
Korean Journal of Dermatology 2005;43(2):249-251
We report a case of alopecia mucinosa in a 9-year-old girl. She presented with several papules on an erythematous patch on the right side of the ala nasi, a hairless nodular lesion on the same side of the nasal canal. Histopathologic findings obtained from the nasal canal revealed typical features of alopecia mucinosa, such as reticular degeneration, cystic space formation and mucin deposition in the pilosebaceous follicle. The case displayed no evidence or clinical features of any malignant changes, and we suspect the case to be an acute form of alopecia mucinosa.
Alopecia*
;
Child*
;
Female
;
Humans
;
Mucinosis, Follicular*
;
Mucins
3.A Case of Anagen Effluvium Induced by INH (Isonicotinic Acid Hydrazide).
Kyung Lok KIM ; Eui Chang JUNG ; Seong Eon KIM ; Sang Hoon KIM ; Ai Young LEE
Korean Journal of Dermatology 2006;44(1):97-99
We report a case of a 30 year-old woman who presented with acute scalp hair loss induced by isonicotinic acid hydrazide gap (INH). Considerable hair loss started within 4 weeks of INH administration. There was no evidence of dermatitis, allergic reaction, or any other cause for the hair loss. INH was discontinued, and the hair loss stopped within 4 weeks, with new hair growth seen. There was complete recovery of hair loss after 12 weeks of alopecia. Medication-induced hair loss is an occasional adverse effect of many drugs, however hair loss induced by INH has been reported in only 1 case. The complete recovery from anagen effluvium is difficult to explain, but it could have been due to the early discontinuance of INH.
Adult
;
Alopecia
;
Dermatitis
;
Female
;
Hair
;
Humans
;
Hypersensitivity
;
Isoniazid
;
Scalp
4.Efficacy of Interferon-alpha2b in Treatment of Warts.
Kyung Lok KIM ; Jung Sub YEUM ; Seong Eon KIM ; Dea Won KOO ; Ai Young LEE
Korean Journal of Dermatology 2005;43(10):1326-1331
BACKGOUND: Interferon-alpha2b has already proven to be effective in the clinical treatment of virus-originated diseases such as hairy cell leukemia, condyloma acuminatum, and AIDS-related Kaposi's sarcoma. The use of recombinant interferon-alpha2b may allow various types of wart to be treated relatively atraumatically and with less incidence of recurrence. OBJECTIVE: We tried to compare the effectiveness and safety of intralesional injections of recombinant interferon-alpha2b with natural interferon-alpha2b in the treatment of patients with various types of wart. METHOD: Patients with more than two warts were treated by injecting the different warts with 0.5 to 1.0X105 IU/1mm3 of recombinant and natural interferon-alpha2b, twice per week for 4 to 20 weeks. The response to treatment was followed up at 36 weeks. RESULTS: At the end of treatment, clearing of the treated warts had occurred in 83.3% of the recombinant interferon-alpha2b group and 91.6% of the natural interferon-alpha2b group. A more rapid cure rate was observed in the natural interferon-alpha2b group than in the recombinant interferon-alpha2b group. The rest showed partial improvement. With evaluation for relapse up to 16 weeks after treatment, warts were found to relapse in 11.1% of both the recombinant and natural interferon groups. CONCLUSION: Intralesional natural interferon-alpha2b has a better therapeutic effect than recombinant interferon-alpha2b, and may be considered as a therapeutic modality of recalcitrant verruca or when it can be anticipated that destructive techniques or blistering agents will not be tolerated.
Blister
;
Humans
;
Incidence
;
Injections, Intralesional
;
Interferons
;
Leukemia, Hairy Cell
;
Recurrence
;
Sarcoma, Kaposi
;
Warts*
5.A Case of Bednar Tumor.
Kyung Lok KIM ; Jung Sub YEUM ; Eui Chang JUNG ; Ai Young LEE ; Kye Yong SONG
Korean Journal of Dermatology 2005;43(1):134-136
A Bednar tumor is a rare pigmented subtype of dermatofibrosarcoma protuberans (DFSP). The clinical and histopathological findings of Bednar tumors are identical to DFSP, except for the presence of melanin-containing cells within the lesion. We present a case of a Bednar tumor on the left anterior chest of a 58-years-old woman. It was presented as an asymptomatic, firm, hyperpigmented 1.8x2.7cm sized nodule with surrounding erythematous patch which had been present for over 35 years. The tumor was treated by wide local excision of the lesion. There has been no evidence of recurrence during a 1 year follow-up period.
Dermatofibrosarcoma
;
Female
;
Follow-Up Studies
;
Humans
;
Recurrence
;
Thorax
6.A Case of Diabetic Thick Skin Syndrome.
Kyung Lok KIM ; Eui Chang JUNG ; Ai Young LEE ; Kye Yong SONG
Korean Journal of Dermatology 2004;42(11):1449-1452
The diabetic thick skin syndrome is a common disease in the children of diabetes mellitus. But, it has not been reported in Korea. It is characterized by the stiff joints of hands and the indurated skin of both hands and arms. The simple screening test is prayer sign that patient is unable to bring fingers together because of contractures of proximal and distal interphalangeal joints. We present an 11-year-old Korean child with stiff joints of both hands and waxy, indurated skin of both hands and forearms that had been increasing in extent for the last 4 years.
Arm
;
Child
;
Contracture
;
Diabetes Mellitus
;
Fingers
;
Forearm
;
Hand
;
Humans
;
Joints
;
Korea
;
Mass Screening
;
Religion
;
Skin*
7.Acquired Resistance Mechanism of EGFR Kinase Domain Duplication to EGFR TKIs in Non–Small Cell Lung Cancer
Chaelin LEE ; Miso KIM ; Dong-Wan KIM ; Tae Min KIM ; Soyeon KIM ; Sun-Wha IM ; Yoon Kyung JEON ; Bhumsuk KEAM ; Ja-Lok KU ; Dae Seog HEO
Cancer Research and Treatment 2022;54(1):140-149
Purpose:
Epidermal growth factor receptor kinase domain duplication (EGFR-KDD) is a rare and poorly understood oncogenic mutation in non–small cell lung cancer (NSCLC). We aimed to investigate the acquired resistance mechanism of EGFR-KDD against EGFR-TKIs.
Materials and Methods:
We identified EGFR-KDD in tumor tissue obtained from a patient with stage IV lung adenocarcinoma and established the patient-derived cell line SNU-4784. We also established several EGFR-KDD Ba/F3 cell lines: EGFR-KDD wild type (EGFR-KDDWT), EGFR-KDD domain 1 T790M (EGFR-KDDD1T), EGFR-KDD domain 2 T790M (EGFR-KDDD2T), and EGFR-KDD both domain T790M (EGFR-KDDBDT). We treated the cells with EGFR tyrosine kinase inhibitors (TKIs) and performed cell viability assays, immunoblot assays, and ENU (N-ethyl-N-nitrosourea) mutagenesis screening.
Results:
In cell viability assays, SNU-4784 cells and EGFR-KDDWT Ba/F3 cells were sensitive to 2nd generation and 3rd generation EGFR TKIs. In contrast, the T790M-positive EGFR-KDD Ba/F3 cell lines (EGFR-KDDT790M) were only sensitive to 3rd generation EGFR TKIs. In ENU mutagenesis screening, we identified the C797S mutation in kinase domain 2 of EGFR-KDDBDT Ba/F3 cells. Based on this finding, we established an EGFR-KDD domain 1 T790M/domain 2 cis-T790M+C797S (EGFR-KDDT/T+C) Ba/F3 model, which was resistant to EGFR TKIs and anti-EGFR monoclonal antibody combined with EGFR TKIs.
Conclusion
Our study reveals that the T790M mutation in EGFR-KDD confers resistance to 1st and 2nd generation EGFR TKIs, but is sensitive to 3rd generation EGFR TKIs. In addition, we identified that the C797S mutation in kinase domain 2 of EGFR-KDDT790M mediates a resistance mechanism against 3rd generation EGFR TKIs.
8.The effect of silk fibroin and rhBMP-2 on bone regeneration in rat calvarial defect model.
Jeong Hun NAM ; Kyung Lok NOH ; Eun O PANG ; Woo Geun YU ; Eung Sun KANG ; Hae Yong KWEON ; Seong Gon KIM ; Young Ju PARK
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2010;36(5):366-374
INTRODUCTION: This study evaluated the capability of silk fibroin (SF) and recombinant human bone morphogenetic protein-2 loaded SF (SF-BMP) as a bone defect replacement matrix when grafted in a calvarial bone defect of rats in vivo. MATERIALS AND METHODS: A total 70 calvarial critical size defects (5.0 mm in diameter) made on 35 adult female Sprague-Dawley rats were used in this study. The defects were transplanted with (1) rhBMP-2 loaded silk fibroin graft (SF-BMP: 0.8+10 microg), (2) Silk fibroin (SF: 10 microg), and (3) no graft material (Raw). The samples were evaluated with soft x-rays, alkaline phosphatase activity, calcium/phosphate quantification, histological and histomorphometric analysis at postoperative 4 and 8 weeks. RESULTS: The SF-BMP group (48.86+/-14.92%) had a significantly higher mean percentage bone area than the SF group (24.96+/-11.01%) at postoperative 4 weeks.(P<0.05) In addition, the SF-BMP group (40.01+/-12.43%) had a higher % bone area at postoperative 8 weeks than the SF group (33.26+/-5.15%). The mean ratio of gray scale levels to the host bone showed that the SF-BMP group (0.67+/-0.08) had a higher mean ratio level than the SF group (0.61+/-0.09) at postoperative 8 weeks. These differences were not statistically significant.(P=0.168 and P=0.243, respectively) CONCLUSION: The rhBMP-2 loaded silk fibroin graft revealed fewer immunoreactions and inflammation as well as more new bone formation than the pure silk fibroin graft. Therefore, silk fibroin may be a candidate scaffold for tissue engineered bone regeneration.
Adult
;
Alkaline Phosphatase
;
Animals
;
Bone Morphogenetic Protein 2
;
Bone Regeneration
;
Female
;
Fibroins
;
Humans
;
Inflammation
;
Osteogenesis
;
Rats
;
Rats, Sprague-Dawley
;
Recombinant Proteins
;
Silk
;
Tissue Scaffolds
;
Transforming Growth Factor beta
;
Transplants
9.Exercise Induced Left Bundle Branch Block Accompanied by Chest Pain.
Seung Pyo HONG ; Kang Lok LEE ; Jung Hoon LEE ; Seung Yeon MIN ; Young Hyo LIM ; Jin Ho SHIN ; Kyung Soo KIM
Journal of the Korean Geriatrics Society 2014;18(3):169-171
Exercise-induced left bundle branch block is a rare condition that has been reported along with and without demonstrable cardiac abnormalities. We describe the case of a 73-year-old female with chest pain on execration. Coronary angiography revealed normal findings. She underwent a treadmill stress test. During the exercise left bundle branch block with concomitant chest pain was demonstrated. Chest pain was relieved with cessation of exercise.
Aged
;
Bundle-Branch Block*
;
Chest Pain*
;
Coronary Angiography
;
Exercise Test
;
Female
;
Humans
10.Forced Eruption of Severe Angulated and Impacted Permanent Teeth after Marsupialization of Dentigerous Cyst: Case Report
Jeong Hun NAM ; Kyung Lok NOH ; Woo Geun YOO ; Byeong Min LEE ; Ji Hyeon JEON ; Su Hyun PARK ; Jang Hoon AHN ; Jung Hee KIM
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 2011;33(1):83-88
Bicuspid
;
Child
;
Dentigerous Cyst
;
Female
;
Humans
;
Mouth
;
Orthodontic Extrusion
;
Tooth
;
Tooth, Deciduous
;
Tooth, Impacted